Under 30 Alum Mammoth Biosciences To Develop Diagnostics For Department Of Defense

Mammoth Biosciences gets funding to develop Crispr based tests to detect biological threats. Company's CEO, Trevor Martin, says his goal is to develop an easy-to-use and a cost effective test which could be easily accessible.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive